Aktiia, a pioneer in optical blood pressure monitoring, announced today that it has received U.S. Food and Drug ...

Healthcare technology company Aktiia has received FDA 510(k) clearance for its over-the-counter cuffless blood pressure ...

Aktiia, a pioneer in continuous blood pressure monitoring, has secured FDA 510(k) clearance for its medical-grade G0 Blood ...

Neuchâtel, Switzerland-based Aktiia said its G0 Blood Pressure Monitoring System will be available in the U.S. in 2026.

The FDA has cleared its first cuffless blood pressure monitor that will be available over-the-counter, with the Hilo ...

The band can be worn during the day and night, allowing patients to track blood pressure patterns across a 24-hour cycle.

Aktiia’s clinically validated, medical-grade technology supports a range of public healthcare initiatives, hypertension programmes, and blood pressure research initiatives across a range of ...

Aktiia devices collect an average of 27 blood pressure measurements per day during passive wearing, offering a comprehensive and continuous profile of an individual's blood pressure.

The connected health personal medical devices market size, currently valued at $39.67 billion in 2024, is expected to grow to $45.71 billion in 2025, marking a compound annual growth rate CAGR of 15.2 ...

Molten Ventures (LON: GROW) confirmed the key highlights from its FY25 trading statement published in April, including a positive uptick in portfolio valuations and, in turn, a 4% NAV per share total ...